[o-[Halo(p-tolylsulfonyl)alkyl]benzyl]trimethylsilane Conversion
J . Org. Chem., Vol. 63, No. 7, 1998 2091
methanol yielded an analytical sample (mp 106 °C). Anal.
Calcd for C19H25BrO2SSi: C, 53.64; H, 5.92. Found: C, 53.42;
H, 5.89.
(d), 130.9 (s), 131.3 (d), 131.5 (d), 132.2 (d), 137.5 (d), 145.1
(s), 145.5 (s); MS(EI) m/e (relative intensity) 229.07 (16), 171.12
(27), 129.07 (48), 91.06 (26), 73.05 (100). A portion of the solid
was recrystallized from petroleum ether to obtain an analytical
sample (mp 112-114 °C). Anal. Calcd for C23H31BrO2SSi: C,
57.61; H, 6.52. Found: C, 57.46; H, 6.55.
[o-[1-B r o m o -1-(p -t o ly ls u lfo n y l)p r o p y l]b e n zy l]t r i-
m eth ylsila n e (19b). Alkylation of 9 (2.00 g, 6.01 mmol) with
n-BuLi (2.30 mL, 6.2 mmol, 2.71 M in hexane) and ethyl
bromide (0.47 mL, 6.32 mmol) followed by n-BuLi (2.30 mL,
6.2 mmol, 2.71 M in hexane) and bromine (0.62 mL, 12.0 mmol)
and workup gave an oil which crystallized from methanol to
yield 19b (1.36 g, 52%, mp 92-97 °C): IR (KBr) 1594, 1319,
[o-[1-Br om o-2-m eth yl-1-(p-tolylsu lfon yl)pr opyl]ben zyl]-
tr im eth ylsila n e (19f). Reaction of trimethyl[o-[2-methyl-1-
(p-tolylsulfonyl)propyl]benzyl]silane1b (1.00 g, 2.67 mmol) with
n-BuLi (1.15 mL, 2.80 mmol, 2.44 M in hexane) and bromine
(0.27 mL, 5.3 mmol) and workup gave an oil which after
chromatography on silica gel using 1:19 ethyl acetate:ligroin
yielded 19f, an oil, as the first eluent (1.09 g). Crystallization
from petroleum ether gave pure 19f (mp 89-93 °C, 0.801 g,
1
1304, 1247, 1147, 846 cm-1; H NMR (CDCl3) δ 0.02 (9H, s),
1.11 (3H, t, J ) 7.0 Hz), 2.01 (1H, d, J ) 14.2 Hz), 2.39 (3H,
s), 2.42-2.63 (1H, m), 2.84-3.02 (1H, m), 3.21 (1H, d, J ) 14.2
Hz), 6.84-6.99 (2H, m), 7.05-7.40 (4H, m), 7.3-7.4 (2H, br
d); 13C NMR (CDCl3) δ -0.6, 10.0, 21.6, 26.5, 32.6, 87.5, 123.4,
127.0, 128.9, 129.2, 130.9, 131.3, 131.4, 132.2, 145.0, 145.7;
MS(EI) m/e (relative intensity) 285.05 (35), 283.05 (32), 229.07
(24), 131.09 (39), 91.07 (51), 73.05 (100). Recrystallization from
ligroin yielded an analytical sample of 19b (mp 97-98.5 °C).
Anal. Calcd for C20H27BrO2SSi: C, 54.66; H, 6.19. Found: C,
54.76; H, 6.22.
66%): IR (KBr) 1597, 1316, 1247, 1156, 854 cm-1 1H NMR
;
(CDCl3) δ 0.01 (9H, s), 0.95 (3H, d, J ) 6.5 Hz), 1.57 (3H, d, J
) 6.1 Hz), 2.34 (3H, s), 2.83 (1H, d, J ) 14.4 Hz), 3.45-3.5
1
(1H, m), 6.8-7.2 (7H, m), 7.48-7.53 (1H, m); H NMR (C6D6,
350 K) δ 0.04 (9H, s), 0.88 (3H, d, J ) 6.5 Hz), 1.69 (3H, d, J
) 6.1 Hz), 1.87 (3H, s), 2.03 (1H, d, J ) 14.4 Hz), 3.05 (1H, d,
J ) 14.5 Hz), 3.55 (1H, septet, J ) 6.3 Hz), 6.62-6.72 (3H,
m), 6.83-6.93 (2H, m), 7.36 (2H, d), 7.56-7.60 (1H, d); 13C
NMR (CDCl3) δ -0.4 (q), 20.5 (q), 21.1 (q), 21.5 (q), 26.2 (t),
35.5 (d), 123.7 (d), 128.5 (d), 128.7 (d), 130.9 (d), 132.4 (d), 132.8
(s), 144.6 (s); 13C NMR (C6D6, 350 K) δ -0.2, 21.0, 21.1, 21.5,
26.9, 36.1, 98.5, 124.1, 128.6, 128.7, 131.5, 132.5, 132.7, 133.9,
134.7, 144.0, 144.3; MS(EI) m/e (relative intensity) 145.09 (33),
91.05 (16), 73.04 (100). Recrystallization from ligroin yielded
an analytical sample of 19f. Anal. Calcd for C21H29BrO2SSi:
C, 55.62; H, 6.45. Found: C, 55.79; H, 6.42.
[o-[1-B r o m o -1-(p -t o ly ls u lfo n y l)p e n t y l]b e n zy l]t r i-
m eth ylsila n e (19c). Alkylation of 9 (2.00 g, 6.01 mmol) using
n-BuLi (2.30 mL, 6.2 mmol, 2.71 M in hexane) and 1-bromobu-
tane (0.68 mL, 6.32 mmol) followed by n-BuLi (2.30 mL, 6.2
mmol, 2.71 M in hexane) and bromine (0.61 mL, 12.0 mmol)
yielded an oil which crystallized from methanol to give 19c
(mp 66-72 °C, 0.875 g): IR (KBr) 1596, 1325, 1246, 1148, 850
1
cm-1; H NMR (CDCl3) δ 0.02 (9H, s), 0.91 (3H, t), 1.30-1.50
(3H, m), 1.60-1.69 (1H, m), 1.95 (1H, d, J ) 14.2 Hz), 2.39
(3H, s), 2.43-2.59 (1H, m), 2.80-2.95 (1H, m), 3.16 (1H, d, J
) 14.2 Hz), 6.84-6.97 (2H, m), 7.03-7.22 (4H, m), 7.33-7.38
(2H, d); 13C NMR (CDCl3) δ -0.6, 13.8, 21.6, 22.5, 26.4, 27.5,
38.9, 86.6, 123.4, 127.5, 128.8, 129.2, 130.9, 131.3, 131.4, 132.1,
145.0, 145.4; MS(EI) m/e (relative intensity) 313.08 (15), 311.08
(15), 229.07 (17), 117.07 (56), 73.05 (100). A portion was
recrystallized from ligroin to obtain an analytical sample (mp
69-72 °C). Anal. Calcd for C22H31BrO2SSi: C, 56.52; H, 6.68.
Found: C, 56.61; H, 6.72. The mother liquor was chromato-
graphed on silica gel using 1:15 ethyl acetate:petroleum ether
to yield additional 19c (1.15 g, total yield 72%).
Rea ction of 19a w ith TBAF . P r ep a r a tion of p-Tolyl
1-o-Tolylvin yl Su lfon e (23a ) a n d 7-Meth yl-7-(p-tolylsu l-
fon yl)bicyclo[4.2.0]octa -1,3,5-tr ien e (21a ). TBAF (2.3 mL,
1.0 M in acetonitrile) was added in 90 min to 19a (0.497 g,
1.17 mmol) in acetonitrile (8 mL). The mixture was diluted
with water and extracted with diethyl ether. The organic
phase was washed with water and saturated NaCl, dried over
MgSO4, and concentrated. Crystallization from methanol
yielded 23a (0.137 g, 43%): IR (KBr) 1313, 1147 cm-1; 1H NMR
(CDCl3) δ 1.93 (3H, s), 2.38 (3H, s), 5.76 (1H, s), 6.69 (1H, s),
6.92-7.24 (6H, m), 7.47 (2H, d); 13C NMR (CDCl3) δ 19.2 (q),
21.5 (q), 125.1 (d), 126.4 (t), 128.8 (d), 129.1 (d), 129.4 (d), 130.0
(d), 130.6 (d), 131.6 (s), 135.3 (s), 137.6 (s), 144.5 (s), 150.1 (s);
MS(EI) m/e (relative intensity) 272.09 (12), 117.07 (100);
HRMS calcd for C16H16O2S 272.0871, found 272.0864. Two
recrystallizations from methanol gave an analytical sample
of 23a (mp 90-92 °C). Anal. Calcd for C16H16O2S: C, 70.56;
H, 5.92. Found: C, 70.47; H, 5.97.
[o-[r-Br om o-r-(p -t olylsu lfon yl)p h en et h yl]b en zyl]t r i-
m eth ylsila n e (19d ). Sulfone 9 (3.00 g, 9.02 mmol) in THF
(60 mL) was alkylated with n-BuLi (3.45 mL, 9.3 mmol, 2.71
M in hexane) and benzyl bromide (1.2 mL, 10.1 mmol) followed
by reactions with n-BuLi (3.5 mL, 9.5 mmol, 2.71 M in hexane)
and bromine (0.95 mL, 19 mmol). Product workup and
crystallization from methanol yielded 19d as a white solid
(2.74 g, 60%, mp 129-131 °C): IR (KBr) 1596, 1322, 1247,
The mother liquor was chromatographed on silica gel using
1:9 ethyl acetate: petroleum ether. The first eluent contained
additional 23a (57 mg, 18%, total yield 61%). The next eluent
contained 21a (35 mg, 11%): IR (KBr) 2974, 2929, 1287, 1135
1
1148, 1082, 842 cm-1; H NMR (CDCl3) δ -0.04 (9H, s), 1.82
(1H, d, J ) 14.2 Hz), 2.41 (3H, s), 3.19 (1H, d, J ) 14.3 Hz),
4.00 (1H, d, J ) 16.7 Hz), 4.52 (1H, d, J ) 16.7 Hz), 6.82-
6.90 (1H, m), 7.05-7.25 (10H, m), 7.37-7.42 (2H, d); 13C NMR
(CDCl3) δ -0.6, 21.6, 26.5, 43.2, 85.5, 123.3, 126.7, 127.4, 127.9,
128.9, 129.5, 130.1, 130.7, 131.3, 132.3, 132.7, 134.9, 145.2,
145.2; MS(EI) m/e (relative intensity) 420.06 (2), 347.06 (5),
345.07 (5), 266.14 (8), 229.07 (13), 193.14 (60), 115.05 (22),
91.05 (24), 73.05 (100). An analytical sample (mp 129-130.5
°C) of 19d was obtained by recrystallization from ligroin. Anal.
Calcd for C25H29BrO2SSi: C, 59.87; H, 5.83. Found: C, 59.77;
H, 5.86.
1
cm-1; H NMR (CDCl3) δ 1.84 (3H, s), 2.42 (3H, s), 3.12 (1H,
d, J ) 14.5), 3.76 (1H, d, J ) 14.6), 7.01-7.69 (8H, m); 13C
NMR (CDCl3) δ 18.9, 21.6, 40.4, 69.3, 121.9, 123.4, 127.8, 129.2,
129.8, 129.9, 132.9, 141.8, 143.5, 144.5; MS(EI) m/e (relative
intensity) 272.09 (1), 117.07 (100), 115.06 (32), 91.06 (20);
HRMS calcd for C16H16O2S 272.0871, found 272.0876. Crys-
tallization from ligroin yielded an analytical sample of 21a (mp
103 °C). Anal. Calcd for C16H16O2S: C, 70.56; H, 5.92.
Found: C, 70.62; H, 5.93.
[o-[1-Br om o-1-(p -t olylsu lfon yl)-5-h exen yl]b en zyl]t r i-
m eth ylsila n e (19e). Alkylation of 9 (2.00 g, 6.01 mmol) using
n-BuLi (2.30 mL, 6.2 mmol, 2.71 M in hexane) and 5-bromo-
1-pentene (0.78 mL, 6.6 mmol) followed by n-BuLi (2.30 mL,
6.2 mmol, 2.71 M in hexane) and bromine (0.32 mL, 6.3 mmol)
and workup yielded 19e which was crystallized from methanol
(1.67 g, 58%, mp 110-113 °C): IR (KBr) 1596, 1323, 1246,
Rea ction of 19b w ith TBAF . P r ep a r a tion of 7-Eth yl-
7-(p-tolylsu lfon yl)-bicyclo[4.2.0]octa-1,3,5-tr ien e (21b) an d
p-Tolyl 1-o-Tolylp r op en yl Su lfon e (23b). To 19b (0.498 g,
1.13 mmol) in acetonitrile (10 mL) was added TBAF (2.3 mL,
2.3 mmol, 1.0 M in acetonitrile) in 45 min. After workup, the
product was crystallized from methanol to give 21b (0.140 g,
43%, mp 121-125 °C): IR (KBr) 2976, 2933, 1596, 1284, 1131
1
1
1147, 849 cm-1; H NMR (CDCl3) δ -0.02 (9H, s), 1.44-1.61
cm-1; H NMR (CDCl3) δ 0.92 (3H, t), 2.14 (1H, sextet), 2.31
(1H, m), 1.68-1.87 (1H, m), 1.93 (1H, d, J ) 14.2 Hz), 2.15
(2H, q), 2.40 (3H, s), 2.43-2.59 (1H, m), 2.82-2.97 (1H, m),
3.15 (1H, d, J ) 14.2 Hz), 4.95-5.07 (2H, m), 5.65-5.87 (1H,
m), 6.84-6.95 (2H, m), 7.04-7.23 (4H, m), 7.36 (2H, d); 13C
NMR (CDCl3) δ -0.6 (q), 21.6 (q), 24.7 (t), 26.4 (t), 33.3 (t),
38.7 (t), 86.6 (s), 115.6 (t), 123.4 (d), 127.5 (s), 128.9 (d), 129.2
(1H, sextet), 2.37 (3H, s), 3.18 (1H, d, J ) 14.7 Hz), 3.55 (1H,
d, J ) 14.7 Hz), 6.95-6.98 (1H, m), 7.10-7.15 (1H, m), 7.19-
7.26 (4H, m), 7.62 (2H, d); 13C NMR (CDCl3) δ 9.1, 21.5, 23.7,
36.9, 73.8, 122.9, 123.0, 127.6, 129.1, 129.6, 129.7, 133.2, 141.3,
142.3, 144.4; MS(EI) m/e (relative intensity) 131.09 (100),
116.06 (19), 115.06 (23), 91.05 (58). A portion of 21b, on